| 0 |
NCT04834349 |
M.D. Anderson Cancer Center |
OTHER |
M.D. Anderson Cancer Center |
OTHER |
None |
[Recurrent Head and Neck Squamous Cell Carcino... |
[{'LocationCity': 'Houston', 'LocationContactL... |
Inclusion Criteria:\n\nPatients with biopsy pr... |
Recruiting |
[{'ArmGroupDescription': 'Patients receive NBT... |
Non-Randomized |
80.0 |
Phase 2 |
1.0 |
2.0 |
2021.0 |
2025.0 |
2021 |
-0.044914 |
-0.197093 |
-0.048174 |
| 1 |
NCT04838444 |
Valneva Austria GmbH |
INDUSTRY |
Valneva Austria GmbH |
INDUSTRY |
None |
[Chikungunya Virus Infection] |
[{'LocationCity': 'Phoenix', 'LocationContactL... |
Inclusion Criteria:\n\nSubject participated in... |
Enrolling by invitation |
[{'ArmGroupDescription': None, 'ArmGroupInterv... |
N/A |
375.0 |
Phase 3 |
11.0 |
1.0 |
2021.0 |
2025.0 |
2021 |
0.002014 |
0.138348 |
-0.826292 |
| 2 |
NCT04837820 |
Memorial Sloan Kettering Cancer Center |
OTHER |
Memorial Sloan Kettering Cancer Center |
OTHER |
None |
[Breast Cancer] |
[{'LocationCity': 'Commack', 'LocationContactL... |
Inclusion Criteria:\n\nEnglish-proficient adul... |
Recruiting |
[{'ArmGroupDescription': 'The intervention wil... |
Randomized |
260.0 |
Phase 2 |
4.0 |
3.0 |
2021.0 |
2025.0 |
2021 |
-0.016280 |
-0.096461 |
0.729943 |
| 3 |
NCT04837508 |
Shanghai Miracogen Inc. |
INDUSTRY |
Shanghai Miracogen Inc. |
INDUSTRY |
None |
[Advanced or Metastatic Biliary Tract Cancer] |
[{'LocationCity': 'Bengbu', 'LocationContactLi... |
Inclusion Criteria:\n\nWilling to sign the ICF... |
Recruiting |
[{'ArmGroupDescription': 'MRG002 will be admin... |
N/A |
86.0 |
Phase 2 |
7.0 |
1.0 |
2021.0 |
2022.0 |
2021 |
-0.043959 |
0.004172 |
-0.826292 |
| 4 |
NCT04830449 |
Hanmi Pharmaceutical Company Limited |
INDUSTRY |
Hanmi Pharmaceutical Company Limited |
INDUSTRY |
None |
[Hypertension] |
[{'LocationCity': 'Seoul', 'LocationContactLis... |
Inclusion Criteria:\n\nPatients over 18 years ... |
Recruiting |
[{'ArmGroupDescription': None, 'ArmGroupInterv... |
Randomized |
116.0 |
Phase 3 |
1.0 |
2.0 |
2020.0 |
2021.0 |
2021 |
-0.039187 |
-0.197093 |
-0.048174 |
| ... |
... |
... |
... |
... |
... |
... |
... |
... |
... |
... |
... |
... |
... |
... |
... |
... |
... |
... |
... |
... |
... |
... |
| 88317 |
NCT00553072 |
Sheri Kashmir Institute of Medical Sciences |
OTHER |
Sheri Kashmir Institute of Medical Sciences |
OTHER |
None |
[Perinatal Asphyxia , Moderate to Severe HIE] |
[{'LocationCity': 'Srinagar', 'LocationContact... |
Inclusion Criteria:\n\nBabies eligible for the... |
Completed |
[{'ArmGroupDescription': 'Magnesium sulphate 2... |
Randomized |
40.0 |
Phase 3 |
1.0 |
2.0 |
2004.0 |
2006.0 |
2016 |
-0.075429 |
-0.172691 |
-0.059196 |
| 88318 |
NCT00554164 |
University Hospital, Essen |
OTHER |
University Hospital, Essen |
OTHER |
[{'CollaboratorClass': 'OTHER', 'CollaboratorN... |
[Lymphoma, High-grade] |
[{'LocationCity': 'Essen', 'LocationContactLis... |
Inclusion Criteria:\n\nAggressive B-cell or T-... |
Completed |
[{'ArmGroupDescription': 'Six cycles of the (R... |
Randomized |
1073.0 |
Phase 3 |
1.0 |
4.0 |
2007.0 |
2017.0 |
2017 |
0.156424 |
-0.172691 |
1.421984 |
| 88319 |
NCT00554723 |
CHIMES Society |
OTHER |
CHIMES Society |
OTHER |
[{'CollaboratorClass': 'OTHER_GOV', 'Collabora... |
[Cerebral Infarction, Stroke] |
[{'LocationCity': 'Hong Kong', 'LocationContac... |
Inclusion Criteria:\n\nSubject is aged 18 year... |
Completed |
[{'ArmGroupDescription': 'NeuroAid', 'ArmGroup... |
Randomized |
1100.0 |
Phase 3 |
24.0 |
2.0 |
2007.0 |
2012.0 |
2014 |
0.162484 |
0.470072 |
-0.059196 |
| 88320 |
NCT00559845 |
Hoffmann-La Roche |
INDUSTRY |
Hoffmann-La Roche |
INDUSTRY |
None |
[Breast Cancer] |
[{'LocationCity': 'Napoli', 'LocationContactLi... |
Inclusion Criteria:\n\nfemale participants, >=... |
Completed |
[{'ArmGroupDescription': 'Participants will re... |
N/A |
56.0 |
Phase 2 |
8.0 |
1.0 |
2008.0 |
2015.0 |
2017 |
-0.071838 |
0.022932 |
-0.799786 |
| 88321 |
NCT00558311 |
Idorsia Pharmaceuticals Ltd. |
INDUSTRY |
Idorsia Pharmaceuticals Ltd. |
INDUSTRY |
None |
[Aneurysmal Subarachnoid Hemorrhage] |
[{'LocationCity': 'Phoenix', 'LocationContactL... |
Inclusion Criteria:\n\nMales and females aged ... |
Completed |
[{'ArmGroupDescription': 'A continuous intrave... |
Randomized |
1157.0 |
Phase 3 |
117.0 |
2.0 |
2007.0 |
2010.0 |
2020 |
0.175277 |
3.069070 |
-0.059196 |